Metabolic Disturbance Clinical Trial
Official title:
Investigation of Sucrose-induced Metabolic Adaptation and Biomarkers of Chronic Sucrose Intake in Humans Using a Multi-omic Approach
Verified date | July 2020 |
Source | Northumbria University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With free sugar intake proving to be of a concern within the general public, discovery and validation of a new biomarker will allow for more consistent measurement of sucrose intake. Furthermore, using a multi-omic approach the investigators will identify metabolic perturbations to the metabolome and proteome.
Status | Active, not recruiting |
Enrollment | 60 |
Est. completion date | February 1, 2022 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 64 Years |
Eligibility |
Inclusion Criteria: - Age 19-64, healthy diagnosis Exclusion Criteria: - gastrointestinal issues, doesn't consume sugar |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Northumberland Building | Newcastle Upon Tyne |
Lead Sponsor | Collaborator |
---|---|
Northumbria University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood pressure | Measurement of systolic and diastolic blood pressure | change in blood pressure following one week intervention | |
Primary | Metabolome | Metabolite profiling of urine samples, obtaining a profile of approximately 5000 metabolite intensities in urine | change in the urinary metabolome following one week intervention | |
Primary | Body composition | measurement of body mass index | change in body mass index following one week intervention | |
Primary | Body composition | measurement of percentage body fat | change in percentage body fat following one week intervention | |
Secondary | food diary analysis | measurement of energy, macro and micronutrient intakes from 3-day food diaries | change in dietary intake following the week intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04528004 -
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
|
Early Phase 1 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Completed |
NCT03445234 -
Blueberries, Bananas, Exercise Recovery
|
N/A | |
Recruiting |
NCT04892199 -
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
|
Phase 4 | |
Active, not recruiting |
NCT05070585 -
Isothiocyanates and Metabolic Health
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05494151 -
Metabolic Substrate of Patients With Myocardial Infarction With and Without Modifiable Cardiovascular Risk Factors
|
||
Completed |
NCT04787952 -
Insight Into New Brown Adipose Tissue Activators.
|
||
Completed |
NCT05758857 -
Multiple Risk Factor Intervention Trial
|
N/A | |
Completed |
NCT02689882 -
"Pharmacokinetic Study of Nicotinamide Riboside"
|
Phase 1 | |
Completed |
NCT01674426 -
Pathogenesis of Functional Hypothalamic Amenorrhea
|
N/A | |
Recruiting |
NCT06252922 -
Diet-Induced Changes in GEnetic Material
|
||
Completed |
NCT06326840 -
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
|
N/A | |
Recruiting |
NCT06345937 -
Multiple Risk Factor Intervention Trial (Ms. FIT)
|
N/A | |
Recruiting |
NCT06392360 -
Betaine, Exercise Performance, and Gut Permeability
|
N/A | |
Completed |
NCT04009642 -
Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
|
||
Withdrawn |
NCT03515642 -
Exercise, Gut Microbiota in Sedentary Adults With Overweight
|
N/A | |
Recruiting |
NCT06333184 -
Smoothies and Blood Sugars
|
N/A | |
Not yet recruiting |
NCT05773183 -
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
|
||
Completed |
NCT04266665 -
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
|
Phase 4 | |
Completed |
NCT03697928 -
Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability
|